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Prebiotic fructans are nondigestible carbohydrates with numerous health beneﬁts. Soybean is a rich source of phytonutrients such
as isoﬂavones. The objective of this study was to evaluate the chemopreventive eﬀects of prebiotics (Synergy1) and soybean meal
(SM) at 5% and 10% levels alone and in combination on azoxymethane- (AOM-) induced colon carcinogenesis. After one wk
of acclimatization, Fisher 344 male rats (N = 90) were randomly assigned to 9 groups (n = 10). Control rats (C) were fed AIN-
93G/M.Two s/cinjections ofAOMwereadministered toratsat7 and8wk ofageat16mg/kgbody weight. Ratswerekilled by CO2
asphyxiation at 45wk. Tumor incidence (%) in treatment groups ranged from 40 to 75 compared to 100 in C. Results indicate that
feeding prebiotics and soybean in combination signiﬁcantly reduced incidence of AOM-induced colon tumors with implications
for food industry in the food-product development.
1.Introduction
Cancer is the second most common cause of deaths after
heart disease and accounts for one of every four deaths in
the US [1]. Despite advances in technology and public health
awareness, colon cancer prevalence is expected to increase in
aged population adding economic burden to the nation [2].
Gut-associated cancers are inﬂuenced by diet [3]. Epi-
demiological and experimental studies showed relation
between dietary consumption patterns and prevention of
chronic diseases [4, 5]. Research on diet-disease correla-
tion using epidemiological and animal experiments showed
single nutrient eﬀects in disease prevention [6–8]. How-
ever, nutrition-health interface becomes more apparent by
exploring the synergistic action of foods in animal models
[9]. Recently, research is focused on identifying speciﬁc
combinations of phytochemicals or foods oﬀering greater
chemopreventive potential. Understanding the inﬂuence of
various bioactive compounds on molecular interactions and
immunomodulatory responses led to the emerging strategy
of combinational chemoprevention [10].
Prebiotics are associated positively in the prevention of
colon cancer by modulating colonic environment [11]. A
combination of long-chain inulin and short-chain oligofruc-
tose causes a slow breakdown of fructans which leads to
direct (stimulation of probiotics) and indirect (bone health,
lipid metabolism, and prevents obstipation or diarrhea)
eﬀectsinthecolon.Inadditiontonutritional-healthbeneﬁts,
prebiotics(Synergy1)exhibitscharacteristicfunctionalprop-
erties allowing its incorporation into a wide range of foods
such as dairy, breads, and confectionaries [12].
Epidemiological studies in Asian populations demon-
strate the inﬂuence of soybean consumption in the pre-
vention of certain chronic diseases such as cancer and
osteoporosis [13–15]. Soybean (Glycine max) is unique
with phytochemicals such as isoﬂavones, saponins, phy-
tates, protease inhibitors, phenolic acids, lecithin, dietary
ﬁber, phytosterols, and omega-3-fatty acids. Metabolism of
isoﬂavones such as genistin, daidzein and glycitin occurs
in the presence of gut microﬂora that inﬂuences their
bioavailability [16, 17].2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Colonic adenomas are benign neoplastic polyps resulting
from the accumulation of genetic alterations in normal
colonic epithelium leading to malignant adenocarcinomas
and metastasis [18–20]. Adenomas are useful biomarkers in
evaluating the chemopreventive potential of various foods
at diﬀerent stages of cancer. Colons of F344 rats treated
with AOM (potent colon-speciﬁc carcinogen) share similar
histochemical properties to those of humans [21]. Therefore,
AOM-F344 rat model is most extensively used in colon
cancer research in identifying agents eﬀective in control of
the disease. Azoxymethane, due to its high potency, is usually
administered as two injections with one week apart adequate
dosage to induce colon cancer in rodents [21]. Although
various studies have established the positive health beneﬁts
of prebiotics and soybean, it would be useful to understand
the synergistic actions of these dietary ingredients at speciﬁc
combinations that contribute as signiﬁcant sources of ﬁber
and protein in a normal balanced diet. The objective of
the study was to evaluate the chemopreventive potential of
prebiotics and soybean meal at 5% and 10% alone and in
combinations in reducing colon cancer using a Fisher 344-
rat model.
2.MaterialsandMethods
2.1. Animal Housing and Diets. Ninety Fisher 344 male
weanling rats (21 days old) were obtained from Harlan, Ind,
USA, and housed in stainless steel wire cages at 2 rats per
cage and acclimatized for one wk prior to administration
of experimental diets. Experimental design is illustrated in
Figure 1. Rats were randomly divided, assigned to nine
groups (n = 10), and fed the following diets: AIN-93G/M
as control [22, 23] and treatment groups with prebiotics
(5%), (10%), soybean meal (5%), (10%), prebiotics +
soybean meal (5% + 5%), (10% + 10%), (5% + 10%), and
(10% + 5%). Saline controls were used as negative controls
in the study but not reported. Dietary modiﬁcations were
made to ﬁber, casein and cornstarch (Table 1). All rats
were housed and maintained according to standard protocol.
Biweekly body weights and daily feed intakes were recorded.
The diets were prepared once a month and stored at 4◦C.
Dietary ingredients were obtained from MP Biomedicals
(Costa Mesa, Calif, USA). Prebiotics (Synergy1-Beneo) was
obtained from Orafti (Teinen, Belgium), and soybean meal
was obtained from a local natural food store (Garden
Cove, Huntsville, Ala, USA), its composition is shown in
Table 5. The protocol involving animals was approved by the
Institutional Animal Care and Use Committee of Alabama
A&M University.
2.2. Chemicals. All chemicals excluding Azoxymethane
(Midwestern Research Institute, NCI, Chemical Repository,
Kansas City, Mo, USA) were obtained from Sigma Chemical
Company (St. Louis, Mo, USA).
2.3. Carcinogen Injection and Sample Collection. Colon
tumors were induced by injecting rats with two s/c injections
of azoxymethane (AOM) in saline at 16mg/kg body wt. at 7
and8weeksofage.Tovalidatethepreventiveroleoftestdiets
(Age/Wk) 34 78 2 0 4 1
Acclimatization AOM
Control and treatment diets
AIN-93G/M
AIN-93G
Termination
Replicates: N = 90;n = 10
Figure 1: Experimental design of feeding control and treatment
diets in F344 male rats. Scale is not proportional. (1) Control
diet is based on AIN-93G/M (American Institute of Nutrition—
93Growth/Maintenance) [22, 23]. (2) Treatment diets: 5%, 10%
Prebiotics and Soybean meal fed singly and in combinations. (a)
Rats: N = 90; n = 10 (Replicates = 5), (b) T ± 21◦C; Relative
humidity = 50%, (c) day and night = 12hr. each, (d) Azoxymethane
(AOM/colon speciﬁc carcinogen) dose = 1 6m g / k go fb o d yw e i g h t .
The protocol involving animals was approved by the Institutional
Animal Care and Use Committee of Alabama A&M University.
in colon cancer development, animals were injected with
carcinogenafter3weekadministration ofthetestdiets. At45
week of their age, all rats were killed using CO2 asphyxiation.
Liver, colonic mucosal scrapings (CMS), and cecal samples
were collected and stored at −80◦C until further analysis.
Femurs were harvested for mineral analysis.
2.4. Characterization of Colon Tumors. Tumor number, size,
location,andTBRratio(Tumorspertumorbearingratratio)
were characterized [24].
2.5. Determination of Detoxiﬁcation Enzyme. Glutathione-s-
transferase (GST) activity (μmol/mg) in the liver and CMS
were assayed [25]. Absorbance was measured at 340nm at
the end of 5 minutes of reaction using a microplate reader
(Synergy HT, Biotek, USA).
2.6. Determination of Antioxidative Enzyme. Hepatic catalase
activity (μmol/mg) was measured at 240nm by monitoring
the composition of H2O2 [26]. Total liver superoxide-
dismutase (SOD) activity (μmol/mg) was measured at
480nm using xanthine oxidase as substrate [27].
2.7. Cecal Bacterial Enzyme Assays (β-Glucosidase and β-
Glucuronidase). Bacterial enzyme activity (μmol/mL) of
cecal contents was measured by the rate of p-nitrophenol
release according to the modiﬁed method [28].
2.8. Bone Mineralization. Femurs were dry-ashed and
prepared for analysis of selected minerals (Calcium-Ca,
Phosphorus-P, Magnesium-Mg, Iron-Fe, and Zinc-Zn) in
the bone using inductively coupled plasma (ICP) spec-
troscopy at speciﬁc wavelengths [29].
2.9. Statistical Analysis. Data were analyzed using SAS 9.1
statistical program (SAS, Cary, NC, USA). Results were
expressed as means ± SEM. Signiﬁcant diﬀerences among
the treatment groups were determined by ANOVA, and
means were separated using Tukey’s studentized range test
at P ≤ 0.05.J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 1: Composition of dietsa (AIN93-M).
Ingredients Control
AIN93M
Prebiotic
5%
Prebiotic
10% SM 5% SM 10% Prebiotic
5% + SM 5%
Prebiotic
10% +
SM 10%
Prebiotic
5% +
SM 10%
Prebiotic
10% +
SM 5%
Corn starch 465.7 415.7 365.7 439.7 413.7 389.7 313.7 363.7 339.7
Casein 140 140 140 120 100 120 100 100 120
F i b e r 5 05 05 04 64 2 4 6 4 2 4 2 4 6
Prebiotic 0 50 100 0 0 50 100 50 100
SM 0 0 0 50 100 50 100 100 50
Commonb
Ingredients 344.3 344.3 344.3 344.3 344.3 344.3 344.3 344.3 344.3
aFormulations of diets based on AIN-93M [22, 23].
bCommon ingredients (g): dextrose, 155; sucrose, 100; soybean oil, 40g; mineral mix (AIN-93M), 35; vitamin mix, 10; L-cysteine, 1.8; choline bitatrate, 2.5.
Abbreviations: SM: soybean meal.
Table 2: Feed intake and weight gain in rats fed prebiotic and
soybean meal.
Groups Feed intake (g/day) Weight gain
(g/41wk)
Control (AIN-93G/M) 17.6 ± 0.91 310.2 ± 8.3b
Prebiotic(5%) 18.04 ± 0.6 361.4 ± 5.8a
Prebiotic (10%) 18.92 ± 0.6 370.1 ± 8.98a
SM (5%) 17.2 ± 0.4 353.3 ± 6.3ab
SM (10%) 18.2 ± 0.3 358.5 ± 8.2a
Prebiotic + SM (5% + 5%) 17.8 ± 0.5 327.0 ± 7.8b
Prebiotic + SM
(10% + 10%) 18.1 ± 0.6 285.5 ± 6.3c
Prebiotic + SM
(5% + 10%) 17.2 ± 0.4 333.5 ± 6.0ab
Prebiotic + SM
(10% + 5%) 17.7 ± 0.4 286.6 ± 6.1c
Abbreviations: SM: soybean meal, values are expressed as means ± SEM.
abcMeans in a column with the same letter are not signiﬁcantly diﬀerent
using Tukey’s studentized range test (P ≤ 0.05).
3. Results
3.1. Feed Intake, Weight Gain, Cecal Weight, and Cecal pH.
There were no signiﬁcant diﬀerences in feed intake (g/day)
in rats fed control and treatment diets (Table 2). However,
weight gain (g/41wk) was signiﬁcantly higher in rats fed
prebiotics (5% and 10%) and SM (10%) compared to
control. Rats fed combinational diets of prebiotics + SM
(10% + 10% and 10% + 5%) had signiﬁcantly lower weight
gain compared to rats fed control and other treatment
diets. An inverse relationship was observed between cecal
weight and cecal pH in rats fed control and treatment diets
(Table 3). Cecal weight (g) was lowest in control fed rats.
Ratsfedprebiotics(10%)singlyandincombinationwithSM
(10%), (10% + 5%) had signiﬁcantly higher cecal weight (g)
compared to other treatment fed rats. Among combination
diet fed groups, prebiotics + SM (10% + 10% and 5% +
10%) had signiﬁcantly lower cecal pH compared to other
groups. However, rats fed prebiotics showed signiﬁcantly
Table 3: Eﬀect of prebiotics and soybean meal on cecal weight and
cecal pH.
Groups Total cecal
weight (g)
Cecal wall
weight (g) Cecal pH
Control
(AIN-93G/M) 3.7 ± 0.22c 1.2 ± 0.1b 7.82 ± 0.03a
Prebiotic (5%) 5.0 ± 0.3b 2.9 ± 0.2a 6.4 ± 0.05e
Prebiotic (10%) 7.1 ± 0.4a 3.8 ± 0.3a 6.2 ± 0.10e
SM (5%) 3.9 ± 0.3bc 2.2 ± 0.2ab 7.6 ± 0.05a
SM (10%) 4.3 ± 0.2bc 2.2 ± 0.1ab 7.7 ± 0.04a
Prebiotic + SM
(5% + 5%) 5.1 ± 0.2b 1.9 ± 0.1b 7.3 ± 0.06b
Prebiotic + SM
(10% + 10%) 7.2 ± 0.4a 3.0 ± 0.1a 6.7 ± 0.03d
Prebiotic + SM
(5% + 10%) 5.4 ± 0.5b 2.4 ± 0.2ab 6.9 ± 0.08c
Prebiotic + SM
(10% + 5%) 6.8 ± 0.3a 2.5 ± 0.2ab 6.7 ± 0.04cd
Abbreviations: SM: soybean meal.
Values are expressed as means ± SEM.
abcdeMeans in a column with the same letter are not signiﬁcantly diﬀerent
using Tukey’s studentized range test (P ≤ 0.05).
higher cecal weight (g) and lower cecal pH among the rats
fed singly. Cecal wall weight (g) ranged from 1.2 (control)
to 3.8 (prebiotic-10%), and represents the absorbed residual
fatty acids in the wall of cecum.
3.2. Distribution and Characterization of Colonic Tumors
3.2.1. Tumor Incidence. The percentage tumor incidence in
rats fed control and treatment diets were higher in the
distal colon compared to the proximal (Figure 2(a)). Rats
fed control diet had higher tumor induction in proximal
and distal colons compared to the rats fed treatment diets.
Among the treatment groups, reductions in tumor incidence
(%) in rats fed prebiotics and SM ranged from 25 to 40
compared to C. However, rats fed combinations of prebiotics
and SM (10%) had the lowest tumor incidence (40%).4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 2: (a) Eﬀect of feeding prebiotics and soybean meal on colon tumor incidence (percentage) in F344 male rats. (b) Eﬀect of feeding
prebiotics and soybean meal on colon tumor number (n) in F344 male rats. (c) Eﬀect of feeding prebiotics and soybean meal on colonic
tumor size (mm) in F344 male rats. Values are expressed as means ± SEM. abcdefBars with same letter are not signiﬁcantly diﬀerent using
Tukey’s studentized range test (P ≤ 0.05). (d) Eﬀect of feeding prebiotics and soybean meal on tumors per tumor bearing rat ratio (TBR) in
F344 male rats. N1 represents the number of rats with tumors; N2 is total number of rats at the end of the experiment. Values are expressed
as means ± SEM. abcBars with same letter are not signiﬁcantly diﬀerent using Tukey’s studentized range test (P ≤ 0.05).
3.2.2. Tumor Number. Rats fed control diets had highest
tumor numbers in both proximal (18) and distal colon
( 3 6 ) .R e d u c t i o n s( % )i nt o t a lt u m o r si nr a t sf e dt r e a t m e n t
diets ranged from a low of 77.7 (SM-5%) to high of 90.7
(prebiotics+SM-10%)comparedtoC(Figure2(b)).Among
rats fed treatment diets, prebiotics (10%) and combination
diet fed rats (prebiotics + SM-10%) had the lowest number
of total tumors. No proximal tumors were seen in rats fed
(prebiotics + SM-5%).
3.2.3. Tumor Size. Compared to control fed rats, rats fed
treatment diets had smaller tumor (mm) both in the
proximal and distal colon (Figure 2(c)).Ratsfed control diet,
prebiotics, and SM singly had larger tumor (mm) in distal
than proximal colon. However, rats fed combination diets
of prebiotics + SM (10%, 5% + 10%) had smaller tumor
(mm) in distal colon. Reductions (%) in tumor size (mm)
in rats fed combination diets of prebiotics and SM ranged
from a low of 50 (prebiotics + SM-10%) to high of 77.7
(prebiotics +SM-5%).
3.2.4. Tumors/Tumor-Bearing Rat Ratio (TBR). Rats fed the
control diet had higher (5.4) tumors/tumor-bearing rat
(TBR) ratio (Figure 2(d)). TBR in rats fed treatment diets
ranged from 1.16 to 1.71. TBR ratios were similar in rats fed
combination diets except in rats fed prebiotics + SM (10%).
Reductions (%) in TBR ratio in rats fed single treatment
diets ranged from a low of 62.2 (SM-5%) to high of 71.1
(prebiotics 10%) and in rats fed combination diets ranged
from 73.3 (prebiotics + SM-10%) to 74.2 (5%, 5% + 10%
and 10% + 5%) compared to control. Overall, rats fed
combination diets had reduced TBR, tumor number, and
smaller tumor (mm) compared to rats fed prebiotics and SM
singly (Table 5).J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
3.3. Hepatic and Colonic Glutathione-s-Transferase (GST)
Activities. Liver GST activity (μmol/mg) in rats fed treat-
ment diets was signiﬁcantly higher than control fed rats
(Figure 3(a)). GST activity (μmol/mg) in treatment groups
ranged from a low of 16.4 (SM-5%) to high of 28.3
(prebiotics + SM-10%). There was over two- to fourfold
increase in hepatic GST activity (μmol/mg) in rats fed
treatment diets compared to the control fed rats. Among
treatment groups, rats fed combination diets of prebiotics
+ SM showed signiﬁcantly higher GST activity (μmol/mg)
than rats fed SM singly. Similar trends were observed with
CMS GST activities (μmol/mg) (Figure 3(b)). CMS GST
activities (μmol/mg) were signiﬁcantly higher in rats fed SM
(10%), prebiotics + SM (5%, 10%, 5% + 10%, 10% + 5%)
compared to control fed rats. Among rats fed combination
diets, colonic GST activity (μmol/mg) ranged from a low of
5 . 2( p r e b i o t i c s+S M - 5 % )t oh i g ho f9 . 0( p r e b i o t i c s+S M ) .
3.4. Antioxidative Enzyme Activities. Catalase activity (CAT)
was signiﬁcantly higher in rats fed prebiotic and SM in
combinations compared to the control rats (Figure 4(a)).
Among treatment groups, rats fed prebiotic + SM (10%)
had highest (56.3) catalase activity (μmol/mg), accounting
for a two fold increase in rats fed treatment diets. Rats fed
control diet showed signiﬁcantly lower superoxide dismutase
activity (SOD) (μmol/mg) compared to rats fed treatment
diets (Figure 4(b)). SOD activity (μmol/mg) ranged from a
low of 2.9 ± 0.09 in rats fed the control diet to a high of
8.0 ± 0.11 in rats fed prebiotic + SM (10%). CAT and SOD
activities (μmol/mg) were two–four folds higher in rats fed
combination diets compared to control.
3.5. Cecal Bacterial Enzyme Activities. Rats fed prebiotics
+ SM (10%, 10% + 5%) had signiﬁcantly higher cecal β-
glucosidase activity (μmol/mL) compared to control (Fig-
ure 5(a)). However, no signiﬁcant diﬀerences were observed
in cecal β-glucosidase activity (μmol/mL) between the rats
fed SM singly and prebiotics + SM (5%, 5% + 10%)
a n dt oc o n t r o lf e dr a t s .C e c a lβ-glucuronidase activity
(μmol/mL) was signiﬁcantly higher in rats fed SM (10%)
singly and prebiotics + SM (5% + 10%) compared to control
(Figure 5(b)). Cecal β-glucuronidase activity (μmol/mL)
ranged from a low of 28.9 (prebiotics + SM-10%) to high
of 34.3 (prebiotics + SM (5% + 10%)).
3.6. Bone Mineralization. Minerals measured in femurs were
calcium (Ca), phosphorus (P), magnesium (Mg), iron (Fe),
andzinc(Zn)(Table4).Ca(mg/g)wassigniﬁcantlyhigherin
rats fed SM (10%) singly and in combination with prebiotics
thanratsfedcontroldiets.Amongratsfedcombinationdiets,
prebiotics + SM (10%) group had the highest bone calcium
(mg/g). Phosphorus (mg/g) was signiﬁcantly lower in rats
fed control diet compared to treatment fed rats. Increase
(%) in bone phosphorus (mg/g) was highest (42.6) in rats
fed prebiotics + SM (10% + 5%). Bone Mg (mg/g) was
signiﬁcantly higher in rats fed treatment diets compared
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Figure 3: Eﬀect of feeding prebiotics and soybean meal on (a)
hepatic GST (b) colonic GST activity (μmol/mg) in F344 male rats.
Abbreviations: SM: soybean meal, GST: glutathione-s-transferase.
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Figure 4: Eﬀect of feeding prebiotics and soybean meal on
hepaticantioxidativeenzymeactivities(a)Catalase(b)SODactivity
(μmol/mg) in F344 male rats. Abbreviations: SM: soybean meal,
SOD: Superoxide-dismutase. abcdBars with same letter are not
signiﬁcantly diﬀerent using Tukey’s studentized range test (P ≤
0.05).
to control (2.2). Among treatment fed rats, the group fed
prebiotics + SM (10%) had highest bone Mg (mg/g) (6).
B o n eF ea n dZ n( μg/g) were signiﬁcantly lower in rats
fed control diet compared to treatment fed rats (Table 4).
Although no signiﬁcant diﬀerences were seen in bone Fe
(μg/g) among the treatment groups, there was over twofold
i n c r e a s ei nb o n eF e( μg/g) compared to control fed rats
(53.1).BoneZn(μg/g)amongtreatmentfedratsrangedfrom
530 (SM-5%) to 741 (prebiotics + SM-10%).
4. Discussion
Consumption of a balanced diet rich in various phyto-
chemicals may provide primary prevention against chronic
diseases. This study evaluated the combinational eﬀects of6 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 5: Eﬀect of feeding prebiotics and soybean meal on cecal
bacterial enzyme activities. (a) β-glucosidase. (b) β-glucuronidase
activity (μmol/mL) in F344 male rats. Abbreviations: SM: soybean
meal. abBars with same letter are not signiﬁcantly diﬀerent using
Tukey’s studentized range test (P ≤ 0.05).
prebiotics and soybean in prevention of colon carcinogene-
sis. Although no signiﬁcant diﬀerences were observed in feed
intake (g/rat/day) among control and treatment groups, the
average body weights of rats at the end of the experiment
(41wk) ranged from 300–400g. Rats fed treatment diets in
combination had lower weight gain (g/41wk) compared to
rats fed the control and treatment diets singly. Combined
eﬀects of prebiotics and SM in decreasing weight gain may
be explained by the inﬂuence of short chain fatty acids
(propionate) produced by colonic fermentation exerting
hypolipidemic eﬀects through decreased lipogenesis in liver,
thereby reduced concentration of plasma very low-density
lipoproteins (VLDL) [30–32]. Similar trend was reported
studying the inhibitory eﬀects of diﬀerent inulin fractions
in Fisher 344 male rats [33]. Cecal fermentation of soluble
dietary ﬁber (prebiotics) by intestinal microﬂora is well
documented [34–36]. Cecal weight and cecal pH showed
an inverse relationship in rats fed prebiotics singly and in
speciﬁc combinations (prebiotics + SM-10% + 10%; 10% +
5%). Reduction in cecal pH is critical for balanced colonic
microﬂora to support colon physiology, prevention of
colonic diseases, and in metabolism of phytonutrients such
as isoﬂavones [37]. Increased cecal weight from prebiotics
consumption may result in short chain fatty acids (SCFA)
p r o m o t i n gc e c a lg r o w t ha so b s e r v e din vivo using inulin in
va ri o u ss t u d i e s[ 28,38], wherea positive correlation between
a lower cecal pH and colon tumor reductions was also seen
in our study.
In the current study, we observed a decrease in tumor
incidence (40%–70%) as well as tumor size (mm), tumor
number, and TBR in both proximal and distal sections
in rats fed treatments diets in combinations compared to
the control. Tumor number and tumor size are indicators
of proliferation and angiogenesis/inﬂammation, while TBR
represents tumor multiplicity. Similar results were seen in
rats fed 10% inulin [5]. Changes in tumor growth char-
acteristics observed in rats fed combination diets suggests
antiproliferative, antiangiogenic and overlapping actions of
prebiotics and soybean meal. Indirect defensive mechanisms
of phytochemicals involve either stimulation or inhibition
of crucial detoxiﬁcation and antioxidative enzymes [39, 40].
Detoxiﬁcationofxenobioticsintheliverisaprimarystrategy
of the biological system in cancer prevention. Stimulation of
hepatic and colonic glutathione-s-transferase (GST) activity
(μmol/mg) in rats fed combination diets is indicative of
the protective eﬀects of prebiotics and SM in stimulation
of the enzyme. Colonic GST activity provides residual
detoxiﬁcation eﬀects in xenobiotic metabolism. Our results
areinagreementwithsimilarstudies,whereGSTactivitywas
signiﬁcantlyinducedwhenFisher344maleratswerefedwith
Flax seed meal at 10%, 20% and silymarin at 100, 500, and
1000ppm [41, 42]. Antioxidative enzymes in liver such as
catalaseandsuperoxide-dismutase(SOD)werestimulatedin
rats fed treatment diets with highest activities seen in rats fed
combination diets. Stimulation of antioxidative enzymes by
phytochemicals present in plant foods such as soybean may
be attributed to the structure of polyphenols (OH groups)
and their metabolites such as equol which has enhanced
antioxidative potential [43–45] .V a r i o u ss t u d i e ss u p p o r tt h e
stimulation of antioxidants by phytochemicals as one of
their protective mechanisms in the prevention of chronic
diseases such as cancer [46–48]. Physiologically, induction of
detoxifying and antioxidative enzymes by dietary bioactive
compounds such as soluble ﬁber (prebiotics) and isoﬂavones
(soybean), their byproducts, and metabolites, may con-
tribute to the cellular defensive mechanisms [49–51].
Cecal microﬂora and their enzyme activities play a
prominent role in the pathology of colonic disease. Estab-
lishment and modulation of colonic microﬂora is largely
inﬂuenced by diet [52, 53]. β-glucosidase is a gut microbial
enzyme catalyzing the hydrolysis of isoﬂavone glycan conju-
gates to aglycans, thus enhancing their bioavailability, while
β-glucuronidase are enzymes involved in deconjugation of
glycosylated, sulfated, and glucuronidated forms of metabo-
lites regulated by biliary secretions [54]. In our study, β-
glucosidase and β-glucuronidase (μmol/mL) were higher in
rats fed treatment diets. Our results were in agreement with
a study involving Fisher 344 rats fed fructo-oligosaccharides
(Raftilose P95) [55]. However, results on cecal β-glucosidase
and β-glucuronidase activities are conﬂicting in rats fed
Inulin and sucrose at 5% levels [56]. Experimental studies
in animals and humans have shown positive eﬀects of
ingestingsynbioticsaswellassoybeanisoﬂavonesonmineral
absorption, bone structure, and health [57]. Underlying
mechanisms of calcium absorption in the presence of intesti-
nal fermentation and isoﬂavone metabolites contributing to
a balanced bone remodeling have been illustrated [37]. In
the present study, rats fed combination diets of prebiotics
and SM showed higher bone mineralization compared to
rats fed control and SM singly. Our results corroborate
previous studies [58, 59], which showed the eﬀects of
fructo-oligosaccharides, isoﬂavones, and their metabolites in
maintaining bone health.J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 7
Table 4: Eﬀect of prebiotic and soybean meal on bone health.
Groups Ca (mg/g) P (mg/g) Mg (mg/g) Fe (μg/g) Zn (μg/g)
Control 267.5 ± 11.2d 122.4 ± 1.2d 2.2 ± 0.1c 53.1 ± 0.8b 163.9 ± 24.8f
Prebiotic (5%) 276.1 ± 8.4c 146.2 ± 2.6bc 3.6 ± 0.2b 96.2 ± 2.9a 502.1 ± 6.8e
Prebiotic (10%) 282.6 ± 11.1c 152.9 ± 4.8c 4.0 ± 0.9b 104.1 ± 4.2a 528.6 ± 6.2d
SM (5%) 268.5 ± 26.9d 133.6 ± 1.8c 3.4 ± 0.17b 108.3 ± 5.3a 530.9 ± 9.3d
SM (10%) 277.8 ± 36.5c 141.0 ± 3.4bc 3.8 ± 0.06b 105.6 ± 1.4a 574.5 ± 34.6c
Prebiotic + SM (5% + 5%) 288.9 ± 5.8c 159.3 ± 4.4b 4.1 ± 0.13b 119.1 ± 0.8a 702.8 ± 29.3ab
Prebiotic + SM (10% + 10%) 431.4 ± 3.3a 167.8 ± 2.8ab 6.0 ±0.7a 114.7 ± 5.8a 714.3 ± 35.0a
Prebiotic + SM (5% + 10%) 329.2 ± 14.7bc 166.4 ± 10.9ab 4.5 ± 0.41ab 112.8 ± 8.4a 741.0 ± 34.6a
Prebiotic+SM (10% + 5%) 395.3 ± 1.1b 174.0 ±6.9a 4.1 ± 0.4b 114.9 ± 6.0a 654.4 ± 22.7b
Abbreviations: SM: soybean meal, Ca: Calcium, P: Phosphorus, Mg: Magnesium, Fe: Iron, Zn: Zinc.
Values are expressed as means ± SEM.
abcdefMeans in a column with the same letter are not signiﬁcantly diﬀerent using Tukey’s studentized range test (P ≤ 0.05).
Table 5:Compositionofdefattedwholedrysoybeanmeal(lowfat).
Serving size 19g
Calories 80.00
Calories from fat 15.00
Total fat 1.50g
Saturated fat 0.00g
Trans fat 0.00g
Cholesterol 0.00mg
Sodium 0.00mg
Total carbohydrate 5.00g
Dietary ﬁber 3.00g
Sugars 2.00g
Protein 10.00g
5. Conclusions
Results indicate a pronounced chemopreventive eﬀect of
prebiotics and soybean in combinations rather than when
fedsingly.Reductionsintumorincidence,smallertumorsize
(mm), and lower tumor number may have been attributed
to the direct eﬀects of treatment diets by acting as antipro-
liferative and antiangiogenic factors or by indirect mecha-
nism such as stimulation of detoxifying and antioxidative
enzymes. Interactive mechanisms of prebiotics and soybean
may have contributed to tumor reductions. Prebiotics has
been associated in the prevention of gut-associated disor-
ders and in isoﬂavone metabolism. Metabolites of soybean
isoﬂavonessuchasequolanddes-methylangolensinmayplay
a role in enhancing the chemoprotective role of prebiotics
in colon cancer. Further, exploring the synergistic eﬀects of
phytonutrientsandtheirmetabolitesonmicrobialenzymatic
activities associated with gut, on cellular and molecular
targets such as speciﬁc genes with implications in cancer
prevention, may be promising.
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